Intensity Therapeutics, Inc.
INTS
$3.67
-$0.07-1.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.09% | 23.97% | 48.96% | 27.29% | -0.28% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.83% | -7.38% | 9.05% | -62.02% | 104.20% |
| Change in Net Operating Assets | 153.17% | 80.18% | -456.25% | 199.24% | -120.20% |
| Cash from Operations | 10.01% | 39.90% | 41.72% | 54.44% | -182.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 156.65% | 1,423.03% | 155,766.67% | 4,212.50% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.05% | -267.07% | -- | -- | -- |
| Cash from Financing | 193.01% | 1,652.54% | 124,666.67% | 4,000.00% | 19,146.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,628.13% | 1,156.86% | 130.52% | -51.28% | -110.31% |